Search research articles
Contact Us
Filters
Showing results (41-50 of 204) with videos related to
Page
of 21
Sort By:
JAMA
|
November 28, 1977
Treatment of Parkinson's disease with lergotrile mesylate
A Lieberman, E Estey, M Kupersmith, et al.
Stroke
|
September 1, 1979
Cerebral arteritis in scleroderma
E Estey, A Lieberman, R Pinto, et al.
Leukemia Research
|
February 5, 1999
The short form of PML-RARalpha fusion transcript is associated with poor survival
M Albitar, K S Chang, S Pierce, et al.
Blood
|
January 1, 1996
Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions
V Gandhi, E Estey, M J Keating, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy
V Gandhi, E Estey, M Du, et al.
American Journal of Hematology
|
August 1, 1993
Primary treatment with 2-chlorodeoxyadenosine of low grade lymphomas that produce IgG or IgA immunoglobulin
M A Dimopoulos, D M Weber, E E Estey, et al.
Cancer Research
|
January 1, 1987
Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts
L A Zwelling, E Estey, L Silberman, et al.
Bone Marrow Transplantation
|
July 1, 1990
Premature chromosome condensation in the study of minimal residual disease
W N Hittelman, J D Tigaud, E Estey, et al.
Biochemistry
|
July 14, 1987
Cell cycle stage dependent variations in drug-induced topoisomerase II mediated DNA cleavage and cytotoxicity
E Estey, R C Adlakha, W N Hittelman, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Topoisomerase II as a target of antileukemic drugs
L A Zwelling, E Estey, M Bakic, et al.
Page
of 21
Search research articles
Search
Showing results (41-50 of 204) with videos related to
Sort By:
Page
of 21
JAMA
|
November 28, 1977
Treatment of Parkinson's disease with lergotrile mesylate
A Lieberman, E Estey, M Kupersmith, et al.
Stroke
|
September 1, 1979
Cerebral arteritis in scleroderma
E Estey, A Lieberman, R Pinto, et al.
Leukemia Research
|
February 5, 1999
The short form of PML-RARalpha fusion transcript is associated with poor survival
M Albitar, K S Chang, S Pierce, et al.
Blood
|
January 1, 1996
Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions
V Gandhi, E Estey, M J Keating, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Minimum dose of fludarabine for the maximal modulation of 1-beta-D-arabinofuranosylcytosine triphosphate in human leukemia blasts during therapy
V Gandhi, E Estey, M Du, et al.
American Journal of Hematology
|
August 1, 1993
Primary treatment with 2-chlorodeoxyadenosine of low grade lymphomas that produce IgG or IgA immunoglobulin
M A Dimopoulos, D M Weber, E E Estey, et al.
Cancer Research
|
January 1, 1987
Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts
L A Zwelling, E Estey, L Silberman, et al.
Bone Marrow Transplantation
|
July 1, 1990
Premature chromosome condensation in the study of minimal residual disease
W N Hittelman, J D Tigaud, E Estey, et al.
Biochemistry
|
July 14, 1987
Cell cycle stage dependent variations in drug-induced topoisomerase II mediated DNA cleavage and cytotoxicity
E Estey, R C Adlakha, W N Hittelman, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Topoisomerase II as a target of antileukemic drugs
L A Zwelling, E Estey, M Bakic, et al.
Page
of 21